Professor Alistair McGuire - 15th March 2017, Savile Club

Professor Alistair McGuire
B.A. (Econ); M.Litt (Econ); Phd (Econ)

Professor Alistair McGuire [B.A. (Econ); M.Litt (Econ); Phd (Econ)] is the Professor of Health Economics at LSE Health and Social Care, within the Department of Social Policy at the London School of Economics and Political Science. Prior to this he was Professor of Economics at City University, London after being a Tutor in Economics at Pembroke College, University of Oxford. He has been a visiting Professor at Harvard University, the University of Sydney, the University of York and the Universitat Pompeu Fabra, Barcelona. He has been interested in the economics of health care for over 30 years, with extensive teaching experience and has written numerous books, articles and reports in this area on a wide range of subject matter. He has been involved in a number of major clinical trials as the lead health economist. He has also acted as an advisor to a number of governments and governmental bodies (including the UK government, The UK Competition Commission (investigating private health care delivery in the UK), the UK Medical Research Council (MRC), the UK Economic and Social Science Research Council (ESRC), the UK National Institute for Clinical Excellence (NICE), the German Institut fur Qualitat Wirtschaftlichkeit im Geshundheitswesen (IQWiG)), as well as for a number of international bodies (including the World Bank, the WHO and the IMF) and pharmaceutical companies and health care insurance companies (including BUPA in a Monopolies and Mergers Commission hearing).

Further information on Professor McGuire at:

http://www2.lse.ac.uk/researchAndExpertise/Experts/profile.aspx?KeyValue=a.j.mcguire@lse.ac.uk

The Revolution in Health Care Payment:

What's Going On and Why?

This talk will give a global perspective on the funding of health care and the general global revolution in the reimbursement of health care providers. This will be linked to the growing importance of managed care and Health Technology Assessment authorities, (for example NICE in the UK). The changing landscape in the UK of the NHS will then be covered, relating this to these global trends in reimbursement. This will highlight the growing pressure on health care providers to increasingly bear financial risks in a managed care environment. The funding implications for dentistry will then be addressed. Future trends and an assessment of where we are now and what the implications of Brexit are for the NHS will conclude the talk.